Fig. 3: Luteolin decreased the invasive and migratory abilities of A549 and H460 cells.
From: Decrease of AIM2 mediated by luteolin contributes to non-small cell lung cancer treatment
The migration (a) and the invasion (b) of A549 and H460 cells with the treatment of luteolin (0, 20, 40, and 80 μM) were examined by scratch wound-healing assay and transwell assay, respectively (scale bar = 100 μm). c Western blot assay for protein expression of Vimentin, E-cadherin, and MMP9 in A549 and H460 cells treated with luteolin (0, 20, 40, and 80 μM) for 24 h. *P < 0.05, **P < 0.01, ***P < 0.001 vs control
